Activation of TAK1 by MYD88 L265P drives malignant B-cell Growth in non-Hodgkin lymphoma
2014 · Blood Cancer Journal · 77 citations
https://doi.org/10.1038/bcj.2014.4
E
Esteban Braggio
WinnMed(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
508
Papers
10.3K
Citations
48
h-index
113
i10-index
Esteban Braggio is an academic researcher from WinnMed. The author has contributed to research in topics: Chronic Lymphocytic Leukemia Research & Multiple Myeloma Research and Treatments & Protein Degradation and Inhibitors. The author has an h-index of 48, co-authored 432 publications.
ORCID: 0000-0003-3860-4830Papers by this author
worksLessons from next-generation sequencing analysis in hematological malignancies
2013 · Blood Cancer Journal · 59 citations
https://doi.org/10.1038/bcj.2013.26
Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma
2019 · Blood Cancer Journal · 36 citations
https://doi.org/10.1038/s41408-019-0255-z
KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival
2019 · Leukemia · 33 citations
https://doi.org/10.1038/s41375-019-0444-6
Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African Americans
2021 · Leukemia · 22 citations
https://doi.org/10.1038/s41375-021-01344-9
Exploring BCL2 regulation and upstream signaling transduction in venetoclax resistance in multiple myeloma: potential avenues for therapeutic intervention
2025 · Blood Cancer Journal · 12 citations
https://doi.org/10.1038/s41408-025-01215-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat